Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Gemcitabine and Capecitabine in Patients With Advanced Pancreatic Cancer

This study has been completed.
Sponsor:
Collaborator:
Roche Pharma AG
Information provided by:
Swedish Medical Center
ClinicalTrials.gov Identifier:
NCT00316420
First received: April 18, 2006
Last updated: March 4, 2010
Last verified: March 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2009
  Primary Completion Date: February 2009 (Final data collection date for primary outcome measure)